Presentation is loading. Please wait.

Presentation is loading. Please wait.

Maria Cattoni, MD, Eric Vallières, MD, Lisa M. Brown, MD, Amir A

Published byMerryl Bryan Modified over 5 years ago

Similar presentations

Presentation on theme: "Maria Cattoni, MD, Eric Vallières, MD, Lisa M. Brown, MD, Amir A"— Presentation transcript:

1 External Validation of a Prognostic Model of Survival for Resected Typical Bronchial Carcinoids 
Maria Cattoni, MD, Eric Vallières, MD, Lisa M. Brown, MD, Amir A. Sarkeshik, MD, Stefano Margaritora, MD, Alessandra Siciliani, MD, Andrea Imperatori, MD, Nicola Rotolo, MD, Farhood Farjah, MD, Grace Wandell, MS, Kimberly Costas, MD, Catherine Mann, MD, Michal Hubka, MD, Stephen Kaplan, MD, Alexander S. Farivar, MD, Ralph W. Aye, MD, Brian E. Louie, MD  The Annals of Thoracic Surgery  Volume 104, Issue 4, Pages (October 2017) DOI: /j.athoracsur Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Kaplan-Meier overall survival curves comparison of the four risk classes: class A (blue line), n = 67; class B (green line), n = 111; class C (yellow line), n = 53; class D (purple line), n = 9. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Kaplan-Meier overall survival curves comparison of the four risk classes redefined using the clinical TNM stage: class A (blue line), n = 69; class B (green line), n = 108; class C (yellow line), n = 54; class D (purple line), n = 9. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Kaplan-Meier overall survival curves comparison by seventh edition TNM stage I (blue line [n = 198]), stage II (green line [n = 27]), and stage III (yellow line [n = 15]). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Maria Cattoni, MD, Eric Vallières, MD, Lisa M. Brown, MD, Amir A"

Similar presentations

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease  Srikrishna Sirivella, MD, Isaac Gielchinsky,

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease  Srikrishna Sirivella, MD, Isaac Gielchinsky,
High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients  Danielle K. Farrington, MD, Patrick D. Kilgo,

High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients  Danielle K. Farrington, MD, Patrick D. Kilgo,
Elizabeth A. David, MD, David T

Elizabeth A. David, MD, David T
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,
Repeated Target Vessel Revascularization After Coronary Artery Bypass for In-Stent Restenosis  Jung-Hwan Kim, MD, Seung Hyun Lee, MD, PhD, Hyun-Chel Joo,

Repeated Target Vessel Revascularization After Coronary Artery Bypass for In-Stent Restenosis  Jung-Hwan Kim, MD, Seung Hyun Lee, MD, PhD, Hyun-Chel Joo,
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Comparison of Video-Assisted Thoracoscopic Surgery and Robotic Approaches for Clinical Stage I and Stage II Non-Small Cell Lung Cancer Using The Society.

Comparison of Video-Assisted Thoracoscopic Surgery and Robotic Approaches for Clinical Stage I and Stage II Non-Small Cell Lung Cancer Using The Society.
Chun Chieh Lin, PhD, MBA, Matthew P

Chun Chieh Lin, PhD, MBA, Matthew P
Joshua E. Rosen, BASc, Hari B

Joshua E. Rosen, BASc, Hari B
Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A

Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Lung Cancer Staging: A Case for a New T Definition

Lung Cancer Staging: A Case for a New T Definition
Surgical Ventricular Restoration: Is There Any Difference in Outcome Between Anterior and Posterior Remodeling?  Andrea Garatti, MD, Serenella Castelvecchio,

Surgical Ventricular Restoration: Is There Any Difference in Outcome Between Anterior and Posterior Remodeling?  Andrea Garatti, MD, Serenella Castelvecchio,
Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy  Colin Schieman, MD, Dennis A. Wigle, MD, PhD,

Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy  Colin Schieman, MD, Dennis A. Wigle, MD, PhD,
Is Sleeve Lobectomy Comparable in Terms of Short- and Long-Term Results With Pneumonectomy After Induction Therapy? A Multicenter Analysis  Giacomo Cusumano,

Is Sleeve Lobectomy Comparable in Terms of Short- and Long-Term Results With Pneumonectomy After Induction Therapy? A Multicenter Analysis  Giacomo Cusumano,
Increased Time From Neoadjuvant Chemoradiation to Surgery Is Associated With Higher Pathologic Complete Response Rates in Esophageal Cancer  Talha Shaikh,

Increased Time From Neoadjuvant Chemoradiation to Surgery Is Associated With Higher Pathologic Complete Response Rates in Esophageal Cancer  Talha Shaikh,
Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.
Biventricular Conversion After Single Ventricle Palliation in Patients With Small Left Heart Structures: Short-Term Outcomes  Brian T. Kalish, MD, Puja.

Biventricular Conversion After Single Ventricle Palliation in Patients With Small Left Heart Structures: Short-Term Outcomes  Brian T. Kalish, MD, Puja.

Similar presentations

Ads by Google